SOX5 and breast cancer: In BC, Liu et al demonstrated that circDOCK1 promotes BC progression through modulation of circDOCK1/hsa‐miR‐132‐3p/Sox5 pathway in vitro and in vivo as well as acts as a promising biomarker and therapeutic targets for BC.20